Drug Profile
Tocilizumab biosimilar - Enzene Biosciences
Alternative Names: Tocilizumab - EnzeneLatest Information Update: 20 Jan 2022
Price :
$50
*
At a glance
- Originator Enzene Biosciences
- Class Anti-inflammatories; Antineoplastics; Antirheumatics; Immunotherapies; Monoclonal antibodies; Skin disorder therapies; Vascular disorder therapies
- Mechanism of Action Interleukin 6 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Rheumatoid arthritis